Olfactory receptor neurons project axons to specific glomeruli of the olfactory bulb so that all the sensory input detected by a single type of olfactory receptor protein converges onto one or two glomeruli in each bulb (Ressler et al., 1994; Treloar et al., 2002). An odorant typically binds to many receptor proteins with different affinities and thus at moderate concentrations can activate a substantial subset of all glomeruli (Rubin and Katz, 1999; Meister and Bonhoeffer, 2001; Wachowiak and Cohen, 2001). One of the functions of the olfactory bulb may be to reduce the extent of this rather widespread activation before transmitting the information to higher olfactory centers (Laurent, 1999; Perez-Orive et al., 2002).
Introduction
Olfactory receptor neurons project axons to specific glomeruli of the olfactory bulb so that all the sensory input detected by a single type of olfactory receptor protein converges onto one or two glomeruli in each bulb (Ressler et al., 1994; Treloar et al., 2002 ). An odorant typically binds to many receptor proteins with different affinities and thus at moderate concentrations can activate a substantial subset of all glomeruli (Rubin and Katz, 1999; Meister and Bonhoeffer, 2001; Wachowiak and Cohen, 2001) . One of the functions of the olfactory bulb may be to reduce the extent of this rather widespread activation before transmitting the information to higher olfactory centers (Laurent, 1999; Perez-Orive et al., 2002) .
Considerable evidence demonstrates that the mitral cell output activity differs in several dimensions from the olfactory sensory neuron input (e.g. Kay and Laurent, 1999) . Two circuits have been studied in vitro that could perform center-surround inhibition in the olfactory bulb, one acting via the classical reciprocal synapses between granule cells and the lateral dendrites of mitral cells (Rall et al., 1966) , the other between glomeruli (Aungst et al., 2003) . Both these circuits can directly modify mitral cell output, the former by acting onto their basal dendrites, the latter by acting on the tuft of the apical dendrite inside the glomerulus. The later circuit could, however, also presynaptically inhibit neurotransmitter release from the olfactory receptor axon terminals.
From experiments in vitro it is known that synaptic transmission from olfactory receptor neurons can be modulated by presynaptic GABA B and dopamine D 2 receptors (Nickell et al., 1994; Wachowiak and Cohen, 1999; Ennis et al., 2001; Duchamp-Viret et al., 2002; Wachowiak et al., 2005; McGann et al, 2005a) . In vertebrates the activation of these receptors suppresses synaptic vesicle release by reducing the amount of calcium that enters the axon terminal as a result of an action potential (Wachowiak and Cohen, 1999; Wachowiak et al., 2005) . The component of presynaptic inhibition controlled by GABA could result from spillover within a glomerulus from GABAergic periglomerular neurons activated either directly by the olfactory receptor neurons, or indirectly by activity in interglomerular superficial short axon cells (Aungst et al., 2003) or the mitral/tufted cells (Murphy et al., 2005) .
We studied the effects of blocking presynaptic inhibition in vivo to determine its role in shaping the response to odor stimulation. The spatio-temporal structure of the response to odorants in vivo will be much more complex than the input resulting from electric shocks to the 4 olfactory nerve layer in a slice preparation. In addition, the milieu of the presynaptic terminals might differ substantially in the tonic concentration of neurotransmitters and neuromodulators between in vitro and in vivo preparations. Finally, some of the three-dimensional structure of the olfactory bulb is lost and feedback from higher brain centers is removed in the in vitro preparation.
Here we present evidence that interglomerular center-surround inhibition shapes the odorant-evoked input in vivo via GABAergic presynaptic inhibition at olfactory receptor axon terminals. We used a local drug perfusion protocol to compare the maps of odorant-evoked input to the mouse olfactory bulb under control conditions and after blocking the presynaptic GABA B receptors with the antagonist CGP46381. We find that the GABA B antagonist qualitatively changes the input map in a manner consistent with blockage of interglomerular center-surround inhibition acting presynaptically on the afferent axon terminals.
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Experimental Procedures
Experiments were performed on 24 female C57/BL6 mice that were between 14 and 30 days of age at the time of recording; effects of CGP46381 were not reliably detected in older animals; the penetration of drugs through the dura and brain tissue of older animals may be restricted.
Olfactory receptor neurons were loaded with Calcium Green-1 dextran as described previously (Wachowiak and Cohen, 2001) . During surgery and recording animals were anesthetized with sodium pentobarbital. Bone over one dorsal olfactory bulb was removed, but the dura matter was left intact. The exposed part of the brain was kept immersed in Ringer's solution and covered with a cover slip. CGP46381 was bath-applied by replacing this solution. In control measurements the solution was replaced at the intervals used for the drug protocol. Before addition the replacement solution was heated to 34 o C to approximate the temperature of the exposed portion of the olfactory bulb. A double tracheotomy was performed to allow controlled flow of air through the nasal cavity; the animals breathed freely through the lower canula. All procedures were approved by the Yale University and the Marine Biological Laboratory animal care committees.
Olfactometer. To minimize the possibility of any mechanical response to the introduction of odorant into the airflow we made several modifications, shown in Figure 1 , to the odorant delivery and respiration apparatus described earlier (Lam et al., 2000) . The new olfactometer ( Figure 1a ) was connected so that the saturated odorant vapor, when introduced into the airflow, replaced the equivalent volume of diluent air. This insured that the rate, humidity and direction of airflow over the nares stayed constant throughout a measurement. The artificial respiration system (Figure 1b ) was connected so that the open end of the valve that performed artificial sniffing was taking air in through a partially open tap, which was adjusted so that its resistance to air flow matches the resistance of the nasal passages. This allowed a more precise metering of the flow rate through the nose. An electronic pressure sensor (Honeywell ASCX01DN) connected at the output of the rostrally directed tracheal canula enabled early detection of tracheal collapse.
The concentration of the odorants is given in % of saturated vapor. We selected odorants that activate the visually accessible dorsal portion of the olfactory bulb. The odorants and their concentrations in the 24 preparations were: 2(-)hexanone (1%, n = 11; 2%, n = 1), isoamylacetate (0.4%, n = 1; 1%, n = 2; 1.3%, n = 1; 2%, n = 3) and benzaldehyde (0.4%, n = 1; 2%, n = 3). In the present study we did not attempt to measure the dependence of map alteration on odorant concentration. The blue trace in the top section of Figure 2a illustrates the time course of the Calcium Green-1 fluorescence response from a single glomerulus to a two second presentation of the odorant 2-hexanone at 1% of saturation. The black trace shows the same data temporally filtered with a low-pass Gaussian filter (f 0 = 1.2 Hz); the two black bars below the trace indicate the frames used for the subtractions to make the maps of activity shown in Figure 2b and Figure   4 . The pre-stimulus period of every recording was fit with an exponential decay curve; the extension of this fit into the stimulus period was subtracted from the signal to give the signal amplitude ( Figure 2a ). In the data presented here only the first two seconds after stimulus onset were used in quantifying the response (grey area, Figure 2a The data in Figure 3c comes from 14 preparations where there was a control period with at least three sets of four trials before the drug application and then two sets of four trials in the presence of the GABA B antagonist CGP46381. The last set of four trials before the application of the drug were taken as the baseline data and the last four trials in the presence of CGP46381 were taken as the data in the presence of the drug. For the plots in Figures 6a and 6b we used the glomerulus and the surround dimensions illustrated in Figure 2b . All of the pixels within the delineated surround region were used to measure the cumulative response amplitude of the surround, not just the pixels belonging to previously identified glomeruli; otherwise the manual glomerulus identification process would introduce a bias into the measurement by excluding some glomeruli that were less activated fluorescence of the olfactory bulb before staining the receptor neurons with Calcium Green-1 and thus were unable to subtract the background to obtain a value of the true F/F. The inability to correct for the background fluorescence will tend to reduce the slope seen in Figure   6b . In addition, blurring of the signals from scattering or out-of-focus light would also tend to reduce the slope seen in Figure 6b .
CGP46381 was applied to 14 out of the 24 preparations. A partially overlapping group of 14 preparations had a control period of sufficient duration for the analysis shown in Figure 3a .
Five of the experiments with the drug protocol were rejected for further analysis because the 8 measured effect of the drug was below the 21% threshold of significance (see below). The concentrations of CGP46381 in the Ringer's solution were 1 mM (n = 8) and 0.1 mM (n = 1).
The effects of CGP46381 were not reversible during the 1 hour wash-out periods we used.
Results
We used a fluorescent calcium indicator dye, loaded into the olfactory receptor neurons via the nasal epithelium (Friedrich and Korsching, 1997; Wachowiak and Cohen, 2001) , to monitor the level of presynaptic activity in the receptor nerve terminals in the olfactory bulb glomeruli. Figure 2b illustrates a grey scale map of odorant-induced activity; individual glomeruli are readily distinguishable.
Response stability. To quantify the stability of our preparations we determined the signal amplitudes (Figure 2a Effect of GABA B antagonists on signal amplitude. The brain-penetrant, competitive GABA B antagonist CGP46381 caused a long-lasting increase in the average amplitude of the presynaptic calcium signal when bath-applied at millimolar concentration (Figure 3c ). This effect was dependent on the age of the animal: it was usually present in juvenile mice (14 to 29 days old) and usually absent in mature mice (older than 30 days). We only used the data recorded from animals younger than 30 days. Further, we did not analyze the experiments where the increase of signal amplitude over the course of the protocol was less than 21% above the baseline (the last set of four trials before the application of the drug) amplitude; the probability of the baseline signal fluctuating past this cut-off as a result of noise was measured to be less than 5% as described above. Nine experiments passed these criteria.
Effect of GABA B antagonists on the input map.
Odorant-evoked input maps are altered when GABA B receptors are blocked. Figure 4 shows examples of the alteration from two different preparations. The color scale has been adjusted between the baseline and drug-perfused recordings to compensate for the increase in calcium signal amplitude after the addition of CGP46381 in the glomeruli with the largest signals. In both preparations there is a more prominent activation of many weakly activated areas after presynaptic inhibition is blocked, as would be expected if strongly activated glomeruli normally suppressed the weakly activated ones. In the following we present two different measurements quantifying this observation.
Reduction of Map contrast. First, in Figure 5 we plot cumulative distributions of normalized glomerular signal amplitudes. Figure 5b shows that there is a shift to the right after perfusion with CGP46381 (solid line) compared with the baseline distribution (dashed line; a total of 251 glomeruli in 9 animals; p < 0.001, Kolmogorov-Smirnov test). This is a manifestation of the reduction of input map contrast. Figure 5a shows that no such shift occurred when we compared two measurements from the control dataset where no drug was applied (a total of 367 glomeruli in 14 animals; p > 0.7).
Center-surround Analysis. Next we measured the effect of the GABA B antagonist on the glomerular signal and the surround signal (Figure 2b ) as a function of the relative activation of the glomerulus and the surround. In Figure 6b we plot the ratio of relative change of the amplitudes of glomeruli and their surrounds against the ratio of the amplitude of a glomerulus and its surround before the drug was applied. When presented in this manner, the glomeruli will be distributed along a horizontal line at y = 1 if their amplitudes did not change, but also if all the amplitudes were scaled by a constant. The noise in the measurement is illustrated by the analogous plot (Figure 6a ) from a control dataset, where we only replaced the vehicle. Figure   6b shows that the GABA B antagonist produced a marked correlation between the two quantities which would not be present if the drug had a proportional effect on all glomeruli. To quantify the level of correlation we fit the function y = 1 + a log(x/b) to these data (red lines in the figure): the slope of the best fit is a = 0.53 ± 0.04 (p <0.0001), compared to a = 0.07 ± 0.03 for the control data (optimal value ± s.d.). These results were not significantly affected by excluding the data from glomeruli whose identity was questionable (e.g. the diffuse spot in the lower right of Figure 2b ). Errors in the calculation of F/F resulting from the fact that we did not subtract the background fluorescence (before staining) and blurring of the signals from scattering or out-offocus light would both tend to reduce the slope seen in Figure 6b . The slope of the line in Figure   6b indicates that for glomerular signals that are eight times larger than the average surround, CGP46381 caused an increase in the surround that was approximately twice as large as the increase in the glomerulus. As another control, after perfusion of a D 2 receptor agonist we observed an overall reduction in signal amplitude that was not accompanied by a significant correlation when the data were plotted as in Figure 6 (data not shown). We conclude that strongly-activated glomeruli are relatively less suppressed by GABA-ergic presynaptic inhibition than their surround.
One concern was the possibility that the correlation shown in Figure 6b , as well as the reduction of contrast in Figure 4 and the shift in the cumulative distribution in Figure 5b , are a consequence of a simple non-linearity in the effect of the drug on the population calcium signal.
For example, if strongly activated glomeruli are operating near the saturation of the calcium signal, it is conceivable that the drug could simply have a greater effect on weakly-activated glomeruli, thereby changing quality of the input map but not actually resulting from lateral inhibition. To test for this possibility in Figure 7 we plot the relative change of amplitude of a glomerulus caused by perfusion of CGP46381 against its normalized baseline amplitude, without regard for the surround. This distribution does, indeed, show that weakly activated glomeruli are relatively more affected by the GABA B antagonist, an effect that could be due to either saturation or blocking lateral inhibition. To distinguish the two possibilities we compared the surrounds of only modestly activated glomeruli that show similar baseline activation but undergo a different change after drug perfusion. The noise in the data necessitates the comparison of several glomeruli, so we divided all the glomeruli near the middle of the observed dynamic range into two groups along the median (outlined in red and blue in Figure 7 ). This band was chosen with the following rationale: strongly activated glomeruli were not used because any saturation effects would show here first; weakly activated glomeruli were not used because noise dominates in this region; the band was extended from a normalized amplitude of 0.5 to lower values until enough glomeruli were included to reach a conclusion that was statistically significant. The glomeruli so selected that were more affected by the GABA B antagonist did, in fact, have more strongly activated surrounds before the drug application: the ratio of amplitudes of a glomerulus and its surround is 1.61 ± 0.12 for the more affected (red box), compared to 1.97 ± 0.16 for the less affected (blue box), set of glomeruli (mean ± s.e.m.; p < 0.05, t-test). The glomeruli from the excluded regions show a similar trend, making this pvalue a conservative estimate. Therefore, the alteration of the input map cannot simply be explained by non-linearity alone.
13
Discussion
In this study we investigated the role of presynaptic inhibition of neurotransmitter release from receptor neuron axon terminals in shaping the map of input from the nose to the olfactory bulb in an in vivo mouse preparation. Presynaptic modulation at receptor neuron axon terminals via GABA B and dopamine D 2 receptors has been well established in in vitro preparations (Nickell et al., 1994; Wachowiak and Cohen, 1999 terminals. In addition, the mitral/tufted neurons form a widespread network through the classical dendro-dendritic synapses with granule cells (Rall et al., 1966) . Because of the relatively long space constant of the mitral cell apical dendrite (Djurisic et al., 2004) , membrane potential changes can reliably spread from the soma back to the glomerular tuft. Thus, there are a number of candidate pathways for inhibiting afferent input as a result of activity that is not local to a glomerulus.
Our results indicate that one component of the modification of the presynaptic calcium signal is a relative suppression of the surround of strongly activated glomeruli, which increases the contrast of the input map. The apparent absence of axo-axonic synapses in glomeruli (Bonino et al., 1999; Shepherd and Greer, 1998) suggests that this effect is a result of spillover within a glomerulus of GABA released from periglomerular neurons that are activated by one or more interglomerular circuits. Thus, the presynaptic terminal responds to the average level of 14 GABA within a glomerulus at a timescale of spillover, an order of magnitude slower than direct synaptic communication Several pieces of evidence suggest that the map change we observed is not an artefact of non-linearity of the effect of the GABA B antagonist on the amplitude of the calcium signal.
First, if we select a subset of glomeruli on the basis of their modest level of activation to minimize the possibility of encountering saturation, and without regard for their location in the map, the glomeruli that are nearer strongly-activated regions behave differently under the antagonist than the ones that are further away (Figure 7) . Such an effect cannot be produced by a local, intraglomerular circuit. For instance, while tonic activation of GABA B receptors is likely to introduce a non-linearity into the response to an exogenous GABA B receptor antagonist, the manifestation of this kind of non-linearity will be the same regardless of how distant a glomerulus is from a strongly activated one. In addition, the proximity effect cannot be artificially produced by cross-talk between glomeruli that mixes their signals, such as the scattering of light and the limited spatial resolution of the measurement apparatus, as any indiscriminate mixing will dilute the observed difference.
Second, recent reports point to a nearly linear dependence of the probability of release from olfactory receptor neuron terminals on the extracellular calcium concentration (Murphy et al., 2004; Wachowiak et al., 2005) , and to a nearly linear dependence of release failure probability at a central synapse on the calcium signal reported by an indicator of affinity similar to the one we used (Koester and Johnston, 2005) . These results do not favor a large nonlinearity between the response of our indicator and neurotransmitter release. Thus, because network-mediated center-surround inhibition is expected to create results like those illustrated in responding glomeruli after blocking presynaptic inhibition. Thus, the metric they used to reach the conclusion that lateral inhibition had no effect in vivo must be either insensitive to such an effect or dominated by noise in glomerular response amplitudes.
The relative contribution of the different interglomerular circuits to the modification of the presynaptic input map are unknown. In the future this question might be addressed by recording the maps of the activity of specific juxtaglomerular neuron types through the use of genetically targeted indicators of activity in concert with drugs that selectively inactivate the particular circuits. Similar measurements from the output neurons (mitral/tufted cells) would provide a measure of the sum of all the interglomerular effects generated in the olfactory bulb. Weakly activated glomeruli undergo relatively larger amplitude increases than strongly activated ones in response to CGP46381. When the surrounds of glomeruli with similar baseline signals, with normalized amplitudes between 0.3 and 0.5, are compared the group that shows a greater increase had a significantly stronger-activated surround initially, indicating that the correlation in Figure 5b cannot be explained simply by non-linearity in the effect of the drug. R = A(glomerulus) / A(surround); values are means ± s. e. m. 251 glomeruli from 9 animals.
